Get the Stockscreener App
1.50
1.32%
-0.02
Ernexa Therapeutics Inc stock is traded at $1.50, with a volume of 73,697.
It is down -1.32% in the last 24 hours and down -25.37% over the past month.
Ernexa Therapeutics Inc is a biotechnology company. The company develops transformational new medicines using various cell engineering technologies for cancer and autoimmune diseases. The proprietary technology of the company transforms induced pluripotent stem cells (iPSCs) into induced mesenchymal stem cells (iMSCs), offering potential off-the-shelf treatment solutions without the need for patient-specific cell harvesting.
See More
Previous Close:
$1.52
Open:
$1.5
24h Volume:
73,697
Relative Volume:
0.99
Market Cap:
$11.51M
Revenue:
$598.00K
Net Income/Loss:
$-44.93M
P/E Ratio:
-0.1805
EPS:
-8.31
Net Cash Flow:
$-17.32M
1W Performance:
-5.36%
1M Performance:
-25.37%
6M Performance:
-68.24%
1Y Performance:
-94.62%
1-Day Range:
$1.48
$1.5599
1-Week Range:
$1.48
$1.70
52-Week Range:
$1.48
$28.80
Ernexa Therapeutics Inc Stock (ERNA) Company Profile
Name
Ernexa Therapeutics Inc
Sector
Industry
Phone
(617) 798-6700
Address
1035 CAMBRIDGE STREET, CAMBRIDGE
Compare ERNA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ERNA
Ernexa Therapeutics Inc
|
1.50 | 11.85M | 598.00K | -44.93M | -17.32M | -8.31 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Ernexa Therapeutics Inc Stock (ERNA) Latest News
Ernexa Therapeutics Inc. stock trend outlook and recovery pathWeekly Profit Analysis & Community Supported Trade Ideas - Newser
Screener Results Flag Ernexa Therapeutics Inc. as OversoldInsider Buying & Community Shared Stock Ideas - newsyoung.net
Price action breakdown for Ernexa Therapeutics Inc.Earnings Overview Report & Safe Entry Momentum Stock Tips - Newser
Full technical analysis of Ernexa Therapeutics Inc. stockJuly 2025 Analyst Calls & Low Risk High Reward Ideas - Newser
Using economic indicators to assess Ernexa Therapeutics Inc. potentialQuarterly Performance Summary & Daily Volume Surge Signals - Newser
What’s next for Ernexa Therapeutics Inc. stock priceEarnings Growth Report & Community Trade Idea Sharing - Newser
What moving averages say about Ernexa Therapeutics Inc.Quarterly Growth Report & Expert Curated Trade Setups - Newser
What does recent volatility data suggest for Ernexa Therapeutics Inc.July 2025 PostEarnings & Free AI Powered Buy and Sell Recommendations - Newser
Ernexa Therapeutics Inc. stock outlook for YEAR2025 AllTime Highs & Real-Time Chart Breakout Alerts - Newser
Is Ernexa Therapeutics Inc. forming a bottoming baseQuarterly Trade Review & Weekly Market Pulse Updates - Newser
Analyzing recovery setups for Ernexa Therapeutics Inc. investorsJuly 2025 Snapshot & Weekly Watchlist for Hot Stocks - Newser
How institutional ownership impacts Ernexa Therapeutics Inc. stock2025 Market Outlook & Verified Momentum Stock Alerts - Newser
Long term hold vs stop loss in Ernexa Therapeutics Inc.July 2025 Outlook & Weekly Return Optimization Alerts - Newser
Will Ernexa Therapeutics Inc. stock benefit from AI tech trends2025 Market Outlook & Growth Oriented Trading Recommendations - beatles.ru
What are the future prospects of Ernexa Therapeutics Inc.Portfolio Performance Summary & Pattern Based Trade Signal System - 선데이타임즈
Real time breakdown of Ernexa Therapeutics Inc. stock performanceQuarterly Performance Summary & Daily Market Momentum Tracking - Newser
Should you hold or exit Ernexa Therapeutics Inc. nowCEO Change & AI Forecasted Entry/Exit Points - Newser
What to expect from Ernexa Therapeutics Inc. in the next 30 days2025 Analyst Calls & Weekly High Momentum Picks - Newser
Using Bollinger Bands to evaluate Ernexa Therapeutics Inc.Weekly Trade Analysis & Free Risk Controlled Daily Trade Plans - Newser
Why Ernexa Therapeutics Inc. stock attracts strong analyst attention2025 Volatility Report & Free Technical Confirmation Trade Alerts - Newser
Is Ernexa Therapeutics Inc. showing signs of accumulation2025 Analyst Calls & Risk Adjusted Swing Trade Ideas - Newser
Is Ernexa Therapeutics Inc. stock forming a triangle patternJuly 2025 Big Picture & Reliable Price Breakout Alerts - mustnews.co.kr
Using data models to predict Ernexa Therapeutics Inc. stock movementProduct Launch & Short-Term Trading Opportunity Alerts - Newser
Institutional scanner results for Ernexa Therapeutics Inc.Weekly Trend Recap & Accurate Technical Buy Alerts - Newser
Detecting price anomalies in Ernexa Therapeutics Inc. with AIBreakout Watch & Verified High Yield Trade Plans - Newser
Using R and stats models for Ernexa Therapeutics Inc. forecastingJuly 2025 PreEarnings & Free Fast Entry Momentum Trade Alerts - Newser
Can Ernexa Therapeutics Inc. deliver alphaRate Hike & Low Drawdown Momentum Trade Ideas - thegnnews.com
Will Ernexa Therapeutics Inc. continue its uptrendTrade Risk Assessment & Capital Efficiency Focused Ideas - Newser
Can Traders Expect Breakout From Ernexa Therapeutics Inc. This WeekQuarterly Profit Summary & Daily Profit Maximizing Trade Tips - classian.co.kr
Is Ernexa Therapeutics Inc. still worth holding after the dipJuly 2025 Action & Free Growth Oriented Trading Recommendations - Newser
Ernexa Therapeutics Inc.’s Price Action Aligns with Quant Signals2025 Volume Leaders & High Win Rate Trade Tips - sundaytimes.kr
Why Ernexa Therapeutics Inc. is moving todayBull Run & Free Weekly Watchlist of Top Performers - Newser
What MACD signals say about Ernexa Therapeutics Inc.CEO Change & AI Driven Price Predictions - Newser
Regression Model Predicts Rangebound Movement in Ernexa Therapeutics Inc.Quarterly Market Summary & Weekly High Conviction Trade Ideas - newsyoung.net
Ernexa Therapeutics Inc Stock (ERNA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Ernexa Therapeutics Inc Stock (ERNA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Cherington Charles | 10% Owner |
Apr 02 '25 |
Buy |
0.10 |
3,768,397 |
394,174 |
20,401,602 |
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):